S Tissot-Renaud
Endovascular therapy outcome in isolated posterior cerebral artery occlusion strokes: A multicenter analysis of the Swiss Stroke Registry.
Maulucci F, Disanto G, Bianco G, Pileggi M, Fischer U, Padlina G, Strambo D, Michel P, Kahles T, Nedeltchev K, Fisch U, Bonati L, Kägi G, Escribano Paredes J, Carrera E, Nyffeler T, Bolognese M, Wegener S, Luft A, Schelosky L, Medlin F, von Reding A, Peters N, Tissot-Renaud S, Mono M, Remonda L, Machi P, Psychogios M, Kaesmacher J, Mordasini P, Cereda C. Endovascular therapy outcome in isolated posterior cerebral artery occlusion strokes: A multicenter analysis of the Swiss Stroke Registry. Eur Stroke J 2023; 8:575-580.
13.01.2023Endovascular therapy outcome in isolated posterior cerebral artery occlusion strokes: A multicenter analysis of the Swiss Stroke Registry.
13.01.2023Eur Stroke J 2023; 8:575-580
Maulucci F, Disanto Giulio, Bianco Giovanni, Pileggi Marco, Fischer Ulrike, Padlina Giovanna, Strambo Davide, Michel Pauline, Kahles Timo, Nedeltchev Krassen, Fisch Ugo, Bonati Leo H, Kägi Georg, Escribano Paredes J B, Carrera Emmanuel, Nyffeler T, Bolognese Manuel, Wegener Susanne, Luft Andreas R, Schelosky Ludwig D., Medlin Friedrich, von Reding Andrea, Peters Nienske, Tissot-Renaud S, Mono M-L, Remonda Luca, Machi Paolo, Psychogios M-N, Kaesmacher Johannes, Mordasini Pasquale, Cereda Carlo W
Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study.
Mark M, Rusakiewicz S, Früh M, Hayoz S, Grosso F, Pless M, Zucali P, Ceresoli G, Maconi A, Schneider M, Froesch P, Tarussio D, Benedetti F, Dagher J, Kandalaft L, von Moos R, Tissot-Renaud S, Schmid S, Metaxas Y. Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study. ESMO Open 2022; 7:100446.
12.04.2022Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study.
12.04.2022ESMO Open 2022; 7:100446
Mark M, Rusakiewicz S, Früh M, Hayoz S, Grosso F, Pless M, Zucali PA, Ceresoli G L, Maconi A, Schneider M, Froesch P, Tarussio D, Benedetti F, Dagher J, Kandalaft L, von Moos R, Tissot-Renaud S, Schmid S, Metaxas Y